ZURICH, Jan. 7, 2026 /PRNewswire/ — AL-S Pharma AG, a Swiss-based, single-asset clinical-stage biopharmaceutical company founded and co-owned by Neurimmune and ZURICH, Jan. 7, 2026 /PRNewswire/ — AL-S Pharma AG, a Swiss-based, single-asset clinical-stage biopharmaceutical company founded and co-owned by Neurimmune and

AL-S Pharma to present at the upcoming J. P. Morgan 2026 Annual Healthcare Conference on Thursday, January 15

ZURICH, Jan. 7, 2026 /PRNewswire/ — AL-S Pharma AG, a Swiss-based, single-asset clinical-stage biopharmaceutical company founded and co-owned by Neurimmune and TVM Capital Life Science, is developing AP-101 for Amyotrophic Lateral Sclerosis (ALS). The company today announced that Dr. Michael Salzmann, Chief Executive Officer, and Prof. Angela Genge, MD, Chief Medical Officer, will present at the 44th Annual J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at 8:30 a.m. PT.

AL-S Pharma will present its recently announced positive results from the global Phase 2 study of AP-101 in 73 participants for the treatment of ALS, along with key data updates, including subgroup analyses, supporting plans for a confirmatory Phase 3 study.

About AP-101
AP-101 is an investigational human-derived antibody directed against misfolded superoxide dismutase 1 (SOD1) designed to inhibit the spread of SOD1 pathology in the CNS of ALS patients. AP-101 received orphan drug designations from FDA, EMA and Swissmedic. The Phase 2 study evaluated safety, tolerability, pharmacodynamic (PD) markers, and pharmacokinetics (PK) of AP-101 in patients with sporadic ALS and in patients with mutations in the SOD1 gene.

About AL-S Pharma AG
AL-S Pharma is a Swiss-based single-asset company founded and co-owned by Neurimmune and TVM Capital Life Science to develop AP-101. The company is fully financed by TVM Life Science Innovation I and Neurimmune. AL-S Pharma brings together a seasoned team of biotech and pharmaceutical leaders with expertise spanning drug discovery, translational research, and clinical development. Based on the successful Phase 2 data, AL-S Pharma is currently advancing AP-101 into late-stage development.

Follow AL-S Pharma on LinkedIn.

Contact for Media
John Capodanno (US)
john.capodanno@dgagroup.com
+1 917 750-8649

Contact for AL-S Pharma
Dr. Michael Salzmann
info@al-spharma.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/al-s-pharma-to-present-at-the-upcoming-j-p-morgan-2026-annual-healthcare-conference-on-thursday-january-15-302654540.html

SOURCE AL-S Pharma AG

Market Opportunity
ArchLoot Logo
ArchLoot Price(AL)
$0.0114
$0.0114$0.0114
-2.56%
USD
ArchLoot (AL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Tokyo Fashion Brand Expands Into Bitcoin and AI

Tokyo Fashion Brand Expands Into Bitcoin and AI

The post Tokyo Fashion Brand Expands Into Bitcoin and AI appeared on BitcoinEthereumNews.com. On Wednesday, Japanese casual apparel retailer Mac House announced that shareholders approved a name change to Gyet Co., Ltd., signaling a strategic shift into crypto and digital assets. The move highlights a broader corporate plan centered on cryptocurrency, blockchain, and artificial intelligence. It reflects the company’s ambition to launch a global Bitcoin treasury program, drawing attention from both domestic and international observers. “Yet” and Its Global Significance Gyet’s amended corporate charter introduces wide-ranging digital initiatives, adding cryptocurrency acquisition, trading, management, and payment services. The new objectives also cover crypto mining, staking, lending, and yield farming, as well as blockchain system development, NFT-related projects, and research in generative AI and data center operations. These changes indicate a clear intent to diversify beyond apparel and position the company within global technology and finance sectors. Sponsored Sponsored The rebranding reflects Gyet’s aim to operate with a broader international outlook. Its new name conveys three concepts: “Growth Yet,” “Global Yet,” and “Generation Yet,” signaling a desire to create technology-driven value for future generations while expanding beyond Japan’s domestic market. Bitcoin Purchasing and Mining Gyet declared its digital asset ambitions in June 2025 and in July signed a basic cooperation agreement with mining firm Zerofield. The company has since begun a $11.6 million Bitcoin acquisition program and is testing mining operations in US states such as Texas and Georgia, where electricity costs are relatively low. Its goal of holding more than 1,000 BTC is modest globally, but the model—funding purchases and mining with retail cash flow—remains unusual for an apparel business. Within Japan, Gyet follows companies such as Hotta Marusho and Kitabo, which have also diversified into cryptocurrency activities distinct from their original operations. This move may accelerate corporate Bitcoin holdings as a financial strategy, attract interest in overseas mining ventures by Japanese firms, and…
Share
BitcoinEthereumNews2025/09/18 11:13
Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

The post Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto appeared on BitcoinEthereumNews.com. Advertisement &nbsp &nbsp Forward Industries, the largest publicly traded Solana treasury company, has filed a $4 billion at-the-market (ATM) equity offering program with the U.S. SEC  to raise more capital for additional SOL accumulation. Forward Strategies Doubles Down On Solana Strategy In a Wednesday press release, Forward Industries revealed that the 4 billion ATM equity offering program will allow the company to issue and sell common stock via Cantor Fitzgerald under a sales agreement dated Sept. 16, 2025. Forward said proceeds will go toward “general corporate purposes,” including the pursuit of its Solana balance sheet and purchases of income-generating assets. The sales of the shares are covered by an automatic shelf registration statement filed with the US Securities and Exchange Commission that is already effective – meaning the shares will be tradable once they’re sold. An automatic shelf registration allows certain publicly listed companies to raise capital with flexibility swiftly.  Kyle Samani, Forward’s chairman, astutely described the ATM offering as “a flexible and efficient mechanism” to raise and deploy capital for the company’s Solana strategy and bolster its balance sheet.  Advertisement &nbsp Though the maximum amount is listed as $4 billion, the firm indicated that sales may or may not occur depending on existing market conditions. “The ATM Program enhances our ability to continue scaling that position, strengthen our balance sheet, and pursue growth initiatives in alignment with our long-term vision,” Samani said. Forward Industries kicked off its Solana treasury strategy on Sept. 8. The Wednesday S-3 form follows Forward’s $1.65 billion private investment in public equity that closed last week, led by crypto heavyweights like Galaxy Digital, Jump Crypto, and Multicoin Capital. The company started deploying that capital this week, announcing it snatched up 6.8 million SOL for approximately $1.58 billion at an average price of $232…
Share
BitcoinEthereumNews2025/09/18 03:42
Will 2026 Be Another Pro-Crypto Year Under Trump 2.0?

Will 2026 Be Another Pro-Crypto Year Under Trump 2.0?

SEC Commissioner Caroline Crenshaw’s departure leaves the agency without a Democratic voice, strengthening Republican control and clearing the path for a more crypto
Share
Blockhead2026/01/09 19:30